Skip to main content
. Author manuscript; available in PMC: 2014 Apr 3.
Published in final edited form as: Br J Dermatol. 2013 Feb;168(2):326–332. doi: 10.1111/bjd.12083

Table 2.

Genotype and allele frequencies among patients (N = 634) and controls (N = 393)

Polymorphism Genotype Patients n (%)a Controls n (%)a Odds ratio (95% confidence interval)
R501X AA 587 (94.5) 350 (97.5)
Aa 34 (5.5) 9 (2.5)
aa 0 (0.0) 0 (0.0)
Wild-type allele 1208 (97.3) 709 (98.7) 1.00
Mutation allele 34 (2.7) 9 (1.3) 2.25 (1.07 – 4.75)*
2282del4 AA 567 (90.6) 350 (95.1)
Aa 58 (9.3) 18 (4.9)
aa 1 (0.2) 0 (0.0)
Wild-type allele 1192 (95.2) 718 (97.6) 1.00
Mutation allele 60 (4.8) 18 (2.4) 2.02 (1.17 – 3.49)*
R2447X AA 599 (99.2) 345 (99.4)
Aa 5 (0.8) 2 (0.6)
aa 0 (0.0) 0 (0.0)
Wild-type allele 1203 (99.6) 692 (99.7) 1.00
Mutation allele 5 (0.4) 2 (0.3) 1.44 (0.28 – 7.46)
S3247X AA 608 (99.2) 357 (99.7)
Aa 5 (0.8) 1 (0.3)
aa 0 (0.0) 0 (0.0)
Wild-type allele 1221 (99.6) 715 (99.9) 1.00
Mutation allele 5 (0.4) 1 (0.1) 2.94 (0.34 – 25.23)
Combined AA 499 (84.1) 299 (91.7)
Aa 87 (14.7) 27 (8.3)
aab 7 (1.2) 0 (0.0)
Wild-type allele 1085 (91.5) 625 (95.9) 1.00
Mutation allele 101 (8.5) 27 (4.1) 2.09 (1.33 – 3.28)*
a

Total number of subjects may differ between polymorphisms due to genotyping failures

b

Homozygous or compound heterozygous

*

Significant at p < 0.05